References
-
1
Vader J P, Burnand B, Froehlich F, Dubois R W, Bochud M, Gonvers J J.
The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): Project and methods.
Endoscopy.
1999;
31
572-578
-
2
Vader J P, Froehlich F, Dubois R W, Beglinger C, Wietlisbach V, Pittet V, Ebel N, Gonvers J J, Burnand B.
The European Panel on the Appropriateness of Gastrointestinal Endoscopy (EPAGE): Conclusions and WWW site.
Endoscopy.
1999;
31
687-694
-
3
Rutgeerts P, Vantrappen G, Geboes K.
Endoscopy in inflammatory bowel disease.
Scand J Gastroenterol Suppl.
1989;
170
12-15
-
4
Mantzaris G J, Hatzis A, Archavlis E, Petraki K, Lazou A, Triantafyllou G, Raptis S A.
The role of colonoscopy in the differential diagnosis of acute, severe hemorrhagic colitis.
Endoscopy.
1995;
27
645-653
-
5
Schumacher G, Sandstedt B, Kollberg B.
A prospective study of first attacks of inflammatory bowel disease and infectious colitis - Clinical findings and early diagnosis.
Scand J Gastroenterol.
1994;
29
265-274
-
6
Geboes K, Delabie J, Rutgeerts P, Vantrappen G.
Endoscopy as a diagnostic tool in inflammatory bowel disease.
Acta Chirurgica Belgica.
1989;
89
106-110
-
7
Podolsky D K.
Inflammatory bowel disease (1).
N Engl J Med.
1991;
325
928-937
-
8
Podolsky D K.
Inflammatory bowel disease (2) (see comments).
N Engl J Med.
1991;
325
1008-1016
-
9
Farmer R G, Easley K A, Rankin G B.
Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients.
Dig Dis Sci.
1993;
38
1137-1146
-
10
Langholz E, Munkholm P, Davidsen M, Nielsen O H, Binder V.
Changes in extent of ulcerative colitis: a study on the course and prognostic factors.
Scand J Gastroenterol.
1996;
31
260-266
-
11
Carbonnel F, Lavergne A, Lemann M, Bitoun A, Valleur P, Hautefeuille P, Galian A, Modgliani R, Rambaud J C.
Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity.
Digestive Diseases & Sciences.
1994;
39
1550-1557
-
12
Hanauer S B, Sninksy C A, Robinson M, Powers B Y, McHattie J D, Mayle J E, Elson C O, DeMicco M P, Butt J H, Pruitt R E, et al.
An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial.
Ann Intern Med.
1996;
124
204-211
-
13
Courtney M G, Nunes D P, Bergin C F, O'Driscoll M, Trimble V, Keeling P W, Weir D G.
Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis.
Lancet.
1992;
339
1279-1281
-
14
Landi B, Anh T N, Cortot A, Soule J C, Rene E, Gendre J P, Bories P, See A, Metman E H, Florent C, et al.
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial: The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.
Gastroenterology.
1992;
102
1647-1653
-
15
Farmer R G, Whelan G, Fazio VW.
Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis.
Gastroenterology.
1985;
88
1818-1825
-
16
Bo-Linn G W, Vendrell D D, Lee E, Fordtran J S.
An evaluation of the significance of microscopic colitis in patients with chronic diarrhea.
Journal of Clinical Investigation.
1985;
75
1559-1569
-
17
Rutgeerts P, Lofberg R, Malchow H, Lamers C, Olaison G, Jewell D, Danielsson A, Goebell H, Thomsen O O, Lorenz-Meyer H, et al.
A comparison of budesonide with prednisolone for active Crohn's disease.
N Engl J Med.
1994;
331
842-845
-
18
Greenberg G R, Feagan B G, Martin F, Sutherland L R, Thomson A B, Williams C N, Nilsson L G, Persson T.
Oral budesonide for active Crohn's disease. Canadian inflammatory bowel disease study group.
N Engl J Med.
1994;
331
836-841
-
19
Vasen H F, Taal B G, Nagengast F M, Griffioen G, Menko F H, Kleibeuker J H, Offerhaus G J, Meera Khan P.
Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families.
Eur J Cancer.
1995;
31
1145-1148
-
20
Greenstein A J, Sachar D B, Smith H, Janowitz H D, Aufses A H.
A comparison of cancer risk in Crohn's disease and ulcerative colitis.
Cancer.
1981;
48
2742-2745
-
21
Ekbom A, Helmick C, Zack M, Adami H O.
Ulcerative colitis and colorectal cancer. A population-based study.
N Engl J Med.
1990;
323
1228-1233
-
22
Bernstein C N, Shanahan F, Weinstein W M.
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?.
Lancet.
1994;
343
71-74
-
23
Ransohoff D F.
Colon cancer in ulcerative colitis.
Gastroenterology.
1988;
94
1089-1091
-
24
Jain S K, Peppercorn M A.
Inflammatory bowel disease and colon cancer - a review.
Digestive Diseases.
1997;
15
243-252
-
25
Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granqvist S.
Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation.
Scan J Gastroenterol.
1996;
31
1195-1204
-
26
Connell W R, Lennard-Jones J E, Williams C B, Talbot I C, Price A B, Wilkinson K H.
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis (see comments).
Gastroenterology.
1994;
107
934-944
-
27
Dyck W P, Cloud M L, Offen W W, Matsumoto C, Chernish S M.
Treatment of duodenal ulceration in the United States.
Scand J Gastroenterol Suppl.
1987;
136
47-55
-
28
Melville D M, Jass J R, Morson B C, Pollock D J, Richman P I, Shepherd N A, Ritchie J K, Love S B, Lennard-Jones J E.
Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome.
Hum Pathol.
1989;
20
1008-1014
-
29
Dixon M F, Brown L J, Gilmour H M, Price A B, Smeeton N C, Talbot I C, Williams G T.
Observer variation in the assessment of dysplasia in ulcerative colitis.
Histopathology.
1988;
13
385-397
-
30
Korelitz B I.
Considerations of surveillance, dysplasia, and carcinoma of the colon in the management of ulcerative colitis and Crohn's disease.
Med Clin North Am.
1990;
74
189-199
-
31
Lennard-Jones J E.
Is colonoscopic cancer surveillance in ulcerative colitis essential for every patient?.
Eur J Cancer.
1995;
31
1178-1182
-
32
Collins R H, Feldman M, Fordtran J S.
Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review.
N Engl J Med.
1987;
316
1654-1658
-
33
Axon A T.
Colonic cancer surveillance in ulcerative colitis is not essential for every patient?.
Eur J Cancer.
1995;
31
1183-1186
-
34
Lennard-Jones J E.
Cancer risk in ulcerative colitis: surveillance or surgery.
Br J Surg.
1985;
72
S84-86
-
35
Choi P M, Nugent F W, Schoetz D J, Silverman M L, Haggitt R C.
Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.
Gastroenterology.
1993;
105
418-424
-
36
Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A.
Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study.
Gastroenterology.
1990;
99
1021-1031
-
37
Lashner B A.
Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single university-based surveillance program.
Am J Gastroenterol.
1992;
87
168-175
-
38
Fuson J A, Farmer R G, Hawk A, Sullivan B H.
Endoscopic surveillance for cancer in chronic ulcerative colitis.
Am J Gastroenterol.
1980;
73
120-126
-
39
Matiushichev V B, Soldatov A I.
High energy laser irradiation in the combined treatment of duodenal ulcer.
Klin Med Mosk.
1994;
72
15-16
-
40
Martin L F.
Stress ulcers are common after aortic surgery. Endoscopic evaluation of prophylactic therapy.
American Surgeon.
1994;
60
169-174
-
41
Rozen P, Baratz M, Fefer F, Gilat T.
Low incidence of significant dyplasia in a successful endoscopic surveillance program of patients with ulcerative colitis (see comments).
Gastroenterology.
1995;
108
1361-1370
-
42
Jonsson B, Ahsgren L, Andersson L O, Stenling R, Rutegard J.
Colorectal cancer surveillance in patients with ulcerative colitis.
British Journal of Surgery.
1994;
81
689-691
-
43
Lynch D A, Lobo A J, Sobala G M, Dixon M F, Axon A T.
Failure of colonoscopic surveillance in ulcerative colitis.
Gut.
1993;
34
1075-1080
-
44
Ekbom A, Helmick C, Zack M, Adami H O.
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement.
Lancet.
1990;
336
357-359
-
45
Richards M E, Rickert R R, Nance F C.
Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease.
Annals of Surgery.
1989;
209
764-773
-
46
Craft C F, Mendelsohn G, Cooper H S, Yardley J H.
Colonic “precancer” in Crohn's disease.
Gastroenterology.
1981;
80
578-584
-
47
Hamilton S R.
Colorectal carcinoma in patients with Crohn's disease.
Gastroenterology.
1985;
89
398-407
1 The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE, Lausanne, Switzerland)
Florian FroehlichMD PD
Senior Lecturer in Gastroenterology
Policlinique Médicale Universitaire
Rue César-Roux 19
CH-1005 Lausanne
Switzerland
Telefon: + 41-32-4662955
eMail: florian.froehlich@bluewin.ch
